Full Text View
Tabular View
No Study Results Posted
Related Studies
Seizure Therapy With Intravenous Levetiracetam and Lorazepam (STILL)
This study has been withdrawn prior to enrollment.
( Inability to recruit subjects )
Study NCT00465244   Information provided by Massachusetts General Hospital

First Received on April 23, 2007.   Last Updated on October 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Seizures
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Epilepsy
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Placebo + Lorazepam 3 mg IV
Additional drug interventions recognized in this trial
Etiracetam
Lorazepam
Piracetam
More general drug interventions related to this trial
Anti-Anxiety Agents
Anticonvulsants
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Gastrointestinal Agents
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Nootropic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Massachusetts General Hospital
UCB, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services